Sonnet BioTherapeutics Granted EU Patent for Innovative FHAB Technology
January 29, 2025 - 11:22
Sonnet BioTherapeutics has successfully obtained a patent from the European Patent Office (EPO) for its groundbreaking fully human albumin binding (FHAB) technology. This significant achievement underscores the company’s commitment to advancing therapeutic solutions that leverage the unique properties of human albumin.
The FHAB technology is designed to enhance the delivery and efficacy of various therapeutic agents, potentially transforming treatment options for patients with a range of medical conditions. By utilizing human albumin, Sonnet aims to improve the pharmacokinetics and bioavailability of drugs, thereby optimizing therapeutic outcomes.
This patent not only strengthens Sonnet's intellectual property portfolio but also positions the company as a leader in the biotherapeutics space. With the growing demand for innovative treatment modalities, the successful patent acquisition is expected to facilitate further research and development initiatives. The company is poised to explore new partnerships and collaborations to maximize the potential of its FHAB technology in the healthcare market.
MORE NEWS
November 2, 2026 - 02:04
Insurers Face Growing Pressure as Tech Firms Push Into Retail MarketInsurance companies are confronting a moderate risk of business disruption from artificial intelligence over the next five years, according to industry analysis, as technology firms increasingly...
November 1, 2026 - 04:32
5 insightful analyst questions from Align Technology’s Q3 earnings callAlign Technology`s third quarter results reflected a mix of steady Clear Aligner demand and changes in product mix, especially a shift toward lower-priced scanner configurations. Management pointed...
October 31, 2026 - 01:48
Field Set for World Wide Technology Championship at DiamanteThe FedExCup Fall wraps up its two-week run in Mexico with the World Wide Technology Championship at El Cardonal at Diamante in Los Cabos. As the sixth event of the fall series, the tournament...
October 30, 2026 - 02:15
Rivian Expands Volkswagen Partnership with AI Voice Assistant LicensingRivian announced on October 29, 2026, that it has broadened its joint venture with Volkswagen Group to include licensing of key components from its AI Voice Assistant technology. The move is part...